{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:31:00Z","timestamp":1792373460051,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.vaccine.2005.11.017","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T12:31:18Z","timestamp":1132662678000},"page":"2071-2078","source":"Crossref","is-referenced-by-count":46,"title":["Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis"],"prefix":"10.1016","volume":"24","author":[{"given":"F.E.","family":"Aldwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Lambeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.W.","family":"de Lisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.M.","family":"Buddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.11.017_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jama.273.3.220","article-title":"Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic","volume":"273","author":"Raviglione","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.11.017_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.11.017_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1054\/tube.2000.0266","article-title":"Wildlife disease reservoirs: the epidemiology of Mycobacterium bovis infection in the European badger (Meles meles) and other British mammals","volume":"81","author":"Delahay","year":"2001","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2005.11.017_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0962-8479(92)90129-8","article-title":"Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guerin to molecular biology: a review","volume":"73","author":"Lugosi","year":"1992","journal-title":"Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2005.11.017_bib5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.11.017_bib6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.11.017_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1054\/tube.2000.0254","article-title":"Vaccination of cattle against Mycobacterium bovis","volume":"81","author":"Buddle","year":"2001","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2005.11.017_bib8","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/IAI.56.12.3310-3312.1988","article-title":"Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines","volume":"56","author":"Orme","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.017_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0041-3879(59)80039-8","article-title":"Studies on the effect of isoniazid upon the antituberculous immunity induced by BCG vaccination","volume":"40","author":"Toyohara","year":"1959","journal-title":"Tubercle"},{"key":"10.1016\/j.vaccine.2005.11.017_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.0300-9475.2004.01471.x","article-title":"The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis","volume":"60","author":"Olsen","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2005.11.017_bib11","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/IAI.62.6.2536-2544.1994","article-title":"Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins","volume":"62","author":"Andersen","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.017_bib12","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1128\/IAI.63.5.2033-2040.1995","article-title":"Influence of mouse strain and vaccine viability on T-cell responses induced by Mycobacterium bovis bacillus Calmette\u2013Guerin","volume":"63","author":"Daugelat","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.017_bib13","first-page":"251","article-title":"Stabilisation of BCG vaccines. New approaches to stablisation of vaccine potency","volume":"87","author":"Gheorghiu","year":"1996","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2005.11.017_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0923-2508(90)90132-A","article-title":"Recombinant BCG as a candidate oral vaccine vector","volume":"141","author":"Barletta","year":"1990","journal-title":"Res Microbiol"},{"key":"10.1016\/j.vaccine.2005.11.017_bib15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2005.11.017_bib16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0952-7915(94)90144-9","article-title":"Mucosal immunity to infection with implications for vaccine development","volume":"6","author":"Staats","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2005.11.017_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1054\/tuld.2000.0250","article-title":"The development of wildlife control strategies for eradication of tuberculosis in cattle in Ireland","volume":"80","author":"Gormley","year":"2000","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.vaccine.2005.11.017_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/IAI.71.1.101-108.2003","article-title":"Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice","volume":"71","author":"Aldwell","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.017_bib19","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1128\/IAI.73.3.1903-1905.2005","article-title":"Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis","volume":"73","author":"Aldwell","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.017_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1711.2005.01369.x","article-title":"Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: anatomical sites of bacterial replication and immune activity","volume":"83","author":"Aldwell","year":"2005","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2005.11.017_bib21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0264-410X(03)00539-5","article-title":"Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums","volume":"22","author":"Aldwell","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.017_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/00480169.2005.36564","article-title":"Oral vaccination of brushtail possums (Trichosurus vulpecula) with BCG: immune responses, persistence of BCG in lymphoid organs and excretion in faeces","volume":"53","author":"Wedlock","year":"2005","journal-title":"N Z Vet J"},{"key":"10.1016\/j.vaccine.2005.11.017_bib23","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/j.vaccine.2005.01.150","article-title":"Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis","volume":"23","author":"Buddle","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.017_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.64.1.1-9.1996","article-title":"Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains","volume":"64","author":"Lagranderie","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.017_bib25","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0264-410X(99)00386-2","article-title":"Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice","volume":"18","author":"Lagranderie","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.017_bib26","first-page":"377","article-title":"Intraduodenal vaccination of brushtail possums with bacille Calmette\u2013Guerin enhances immune responses and protection against Mycobacterium bovis infection","volume":"1","author":"Buddle","year":"1997","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2005.11.017_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-1135(94)90005-1","article-title":"Experimental Mycobacterium bovis infection in the brushtail possum (Trichosurus vulpecula): pathology, haematology and lymphocyte stimulation responses","volume":"38","author":"Buddle","year":"1994","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2005.11.017_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0034-5288(95)90095-0","article-title":"Effectiveness of BCG vaccination in protecting possums against bovine tuberculosis","volume":"58","author":"Aldwell","year":"1995","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2005.11.017_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF02774129","article-title":"Functional morphology of microfold cells (M cells) in Peyer's patches-phagocytosis and transport of BCG by M cells into rabbit Peyer's patches","volume":"21","author":"Fujimura","year":"1986","journal-title":"Gastroenterol Jpn"},{"key":"10.1016\/j.vaccine.2005.11.017_bib30","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1128\/JVI.71.3.2303-2309.1997","article-title":"Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice","volume":"71","author":"Lagranderie","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.11.017_bib31","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/bi00460a012","article-title":"Physical\u2013chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings","volume":"29","author":"Hernell","year":"1990","journal-title":"Biochem"},{"key":"10.1016\/j.vaccine.2005.11.017_bib32","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1128\/IAI.68.10.5657-5662.2000","article-title":"Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes","volume":"68","author":"Abolhassani","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.017_bib33","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1128\/IAI.60.7.2880-2886.1992","article-title":"Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice","volume":"60","author":"Huygen","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.017_bib34","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/S0264-410X(00)00134-1","article-title":"Intranasal vaccination of mice against infection with Mycobacterium tuberculosis","volume":"18","author":"Falero-Diaz","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.017_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2249.2001.01667.x","article-title":"Intranasal BCG vaccination protects BALB\/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs","volume":"126","author":"Lyadova","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2005.11.017_bib36","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1086\/313864","article-title":"Mucosal bacille Calmette\u2013Guerin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses","volume":"30","author":"Hoft","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05011618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05011618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T03:10:35Z","timestamp":1586574635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05011618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0264410X05011618"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.11.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}